Frontotemporal Dementia Drug Discovery Program

Published Date
Contact Information
Adam Liebling, 212-901-8005; aliebling@alzdiscovery.org
Deadline
Eligiblity
Nonprofit academic institutions and private, for-profit companies
Program Area
Programe Purpose
To fund research into treatments for frontotemporal dementia